Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression

Islam, Farhana, Gorbovskaya, Ilona, Müller, Daniel J. · 2021 · Advances in Experimental Medicine and Biology

Abstract

Genetic factors play a significant but complex role in antidepressant (AD) response and tolerability. During recent years, there is growing enthusiasm in the promise of pharmacogenetic/pharmacogenomic (PGx) tools for optimizing and personalizing treatment outcomes for patients with major depressive disorder (MDD). The influence of pharmacokinetic and pharmacodynamic genes on response and tolerability has been investigated, including those encoding the cytochrome P450 superfamily, P-glycoprotein, monoaminergic transporters and receptors, intracellular signal transduction pathways, and the stress hormone system. Genome-wide association studies are also identifying new genetic variants associated with AD response phenotypes, which, combined with methods such as polygenic risk scores (PRS), is opening up new avenues for novel personalized treatment approaches for MDD. This chapter describes the basic concepts in PGx of AD response, reviews the major pharmacokinetic and pharmacodynamic genes involved in AD outcome, discusses PRS as a promising approach for predicting AD efficacy and tolerability, and addresses key challenges to the development and application of PGx tests.

Overview

Integrity signals

Registry

Crossref · 10.1007/978-981-33-6044-0_13

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 117 references

Research works printed but not linked: 1

  1. Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, Müller DJ, Shimoda K et al (2017) Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther 102(1):37–44 · DOI · Paper page

Cited by

See all 8

Metadata

Authors
Islam, F., Gorbovskaya, I., & Müller, D. J.
Affiliations
Centre for Addiction and Mental Health (CA)
Venue
Advances in Experimental Medicine and Biology
Published
2021
Volume
1305
Pages
231-255
ISSN
  • 0065-2598 (ISSN-L)
  • 2214-8019
OpenAlex
W3142542217
Cited by
6
References
117
Citations by year
2025: 1 · 2024: 2 · 2022: 3
FWCI
5.04
Type
book chapter
Language
en
Open access
closed
Licence
Locations
  • Advances in experimental medicine and biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
pharmacogenetics, pharmacogenomics, major depressive disorder, antidepressant response, antidepressant tolerability, personalized treatment, polygenic risk score, cytochrome P450, P-glycoprotein, monoaminergic receptors, intracellular signaling, genome-wide association study, pharmacokinetic genes
MeSH terms
Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Pharmacogenetics, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. https://app.cochat.ai/papers/10.1007/978-981-33-6044-0_13
The paper
Islam, F., Gorbovskaya, I., & Müller, D. J. (2021). Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression. Advances in Experimental Medicine and Biology. https://doi.org/10.1007/978-981-33-6044-0_13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.